Article
Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk.
Pharmacogenetics and genomics - 1 Apr 2006
Long Ji-Rong, Egan Kathleen M, Dunning Lisa, Shu Xiao-Ou, Cai Qiuyin, Cai Hui, Dai Qi, Holtzman Jordan, Gao Yu-Tang, Zheng Wei
Abstract excerpt
The aryl hydrocarbon receptor (AhR) is a key regulator of the transcriptional expression for the cytochrome P450 1 (CYP1) genes. CYP1A2 is one of the major CYP1 enzymes that catalyse 2-hydroxylation of estrogen, a hormone that plays a critical role in the etiology of breast cancer. In this study, we investigated whether two common polymorphisms in these two genes, CYP1A2*1F and AhR Lys554Arg, were associated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
